Thursday, 11 June 2015

Fetal Heart Monitoring: What's Normal | Why Use Fetal Monitor Machine During Pregnancy

It’s important to monitor your baby’s heart rate and rhythm to make sure the baby is doing well during the third trimester of your pregnancy and during labor. The fetal heart rate doppler should be between 110 and 160 beats per minute during labor, according to Johns Hopkins Medicine Health Library.
Doctors may use internal or external devices to monitor the fetal heart beat. It’s most often measured using an ultrasound device. Sometimes your doctor will instead attach an internal monitoring device directly to the baby’s scalp to help measure the heart rate more accurately. 
Your doctor will be looking for different kinds of heart rates, including accelerations and decelerations. They’ll watch for any heart-related changes that may occur, as these are often signs that either the baby or the mom is at physical risk. Such signs of risk might prompt the doctor to take immediate action to restore the safety of the fetus and mother.

Accelerations

Doctors will look for accelerations during labor. Accelerations are short-term rises in the heart rate of at least 15 beats per minute, lasting at least 15 seconds. Accelerations are normal. They tell the doctor that the baby has an adequate oxygen supply, which is critical. Most fetuses have spontaneous accelerations at various points throughout the labor and delivery process. Your doctor may try to induce accelerations if they’re worried about the well-being of the baby and don’t see accelerations. They may try one of a few different methods to induce accelerations:


  • gently rocking the mother's abdomen
  • pressing on the baby's head through the cervix with a finger
  • administering a short burst of sound (vibro acoustic stimulation)




Decelerations

Decelerations are temporary drops in the fetal heart rate. There are three basic types of decelerations: early decelerations, late decelerations, and variable decelerations. Early decelerations are generally normal and not concerning. Late and variable decelerations can sometimes be a sign the baby isn’t doing well.

Early Decelerations

Early decelerations can happen when the baby's head is compressed. This often happens during later stages of labor as the baby is descending through the birth canal. They may also occur during early labor if the baby is premature or in a breech position. This causes the uterus to squeeze the head during contractions. Early decelerations are generally not harmful.

Late Decelerations

Late decelerations don’t begin until the peak of a contraction or after the uterine contraction is finished. They’re smooth, shallow dips in heart rate that mirror the shape of the contraction that’s causing them. Sometimes there is no cause for concern with late decelerations, as long as the baby’s heart rate also shows accelerations (this is known as variability).
Late decelerations can be a sign in some cases that the baby isn’t getting enough oxygen. Late decelerations that occur along with a fast heart rate (tachycardia) and very little variability can mean that the contractions may be harming the baby by depriving them of oxygen, for example. Your doctor may opt to begin an urgent (or emergent) cesarean section if late decelerations and other factors indicate that the baby is in danger.

Variable Decelerations

Variable decelerations are irregular, often jagged dips in the fetal monitor rate that look more dramatic than late decelerations. Variable decelerations happen when the baby’s umbilical cord is temporarily compressed. This happens during most labors. The baby depends on steady blood flow through the umbilical cord to receive oxygen and other important nutrients. It can be a sign that the baby’s blood flow is reduced if variable decelerations happen over and over. Such a pattern can be harmful to the baby.
Doctors decide if variable decelerations are a problem or not depending on what else their heart rate monitors tell them. Another factor is how close the baby is to being born. For example, your doctor may want to perform a cesarean section if there are severe variable decelerations early in the labor. It’s considered normal if they happen before delivery and there are accelerations as well.




Friday, 5 June 2015

Blood Test Could Identify Your Entire Viral Infection

Researchers have created what they say is a "one-stop shop" for diagnosing infections - a test that can determine an individual's complete viral history just by scanning a single drop of blood.



The test, called VirScan, was created by Stephen Elledge and colleagues from the Howard Hughes Medical Institute (HHMI).


"We've developed a screening methodology to basically look back in time in people's [blood] sera and see what viruses they have experienced," explains Elledge. "Instead of testing for one individual virus at a time, which is labor intensive, we can assay all of these at once. It's one-stop shopping."

The team explains how VirScan works in a new study published in the journal Science, in which they also reveal how the test performed when tested on the blood samples of more than 500 participants infected with certain viruses.

Elledge and colleagues synthesized over 93,000 short sections of DNA to create the test, each section encoding various pieces of viral proteins, called peptides.

Next, the team introduced the DNA sections to bacteriophages - viruses that invade bacterial cells and infect them. Each bacteriophage molded with a peptide, with the peptide displayed on the bacteriophage's surface.

Together, the bacteriophages show all protein sequences present in the more than 1,000 strains of human viruses currently known.
Explaining how VirScan identifies viruses in blood samples, the researchers note that antiviral antibodies present in the blood recognize unique characteristics known as epitopes, which are found in peptides on the surface of each bacteriophage. When the bacteriophages are combined with a blood sample, antibodies in the blood identify and bind to these epitopes.
The researchers then collect these antibodies and dispose of everything except the bacteriophages they are attached to.
By conducting DNA sequencing on these bacteriophages, the team is able to identify the peptides that the antibodies clung to, revealing which viruses an individual's immune system has come across previously, whether through infection or vaccination.
 
It is likely to take around 2-3 days for VirScan to analyze 100 blood samples, according to Elledge, though he is confident that this processing time can be increased the more the test is developed. It would cost around $25 to analyze one blood sample.
The team found that each individual included in the study had an average of 10 different viruses, with people in South Africa, Peru and Thailand possessing antibodies against more viruses than those in the US.
In addition, they found that adults possessed antibodies against more viruses than children, and individuals with HIV had antibodies to more viruses than those without HIV.
Perhaps the most surprising finding, however, was that antibody responses against certain viruses were found to be similar in each individual; different people's antibodies recognized exactly the same amino acids present in the peptides of specific viruses.
The researchers are confident that VirScan could be an effective alternative to existing viral testing methods, which test for specific viruses one by one.
As the test can determine an individual's viral history, the team believes it offers the potential to uncover factors affecting health that may have been overlooked. The test also provides the opportunity to assess and compare viral infections in large populations, and it may even have implications for vaccine design.
Their study, the researchers say, has helped them improve the accuracy of VirScan, and they hope it will improve further with more research.
The approach used to create VirScan could also be applied to identify other antibodies, the team notes, such as those involved in autoimmune diseases, in which the immune system attacks the body's healthy tissues.

Test showed high sensitivity and specificity
The researchers tested VirScan on the blood samples of 569 people from the US, South Africa, Thailand and Peru, all of whom were known to have been infected with certain viruses, including human immunodeficiency virus (HIV) and hepatitis C.
Overall, VirScan analyzed around 100 million possible interactions between antibodies and epitopes from the blood samples, with the test producing very accurate results, according to the team. Elledge says: